Codelivery of Dual Gases with Metal‐Organic Supramolecular Cage‐Based Microenvironment‐Responsive Nanomedicine for Atherosclerosis Therapy
Small · 2024
DOI: 10.1002/smll.202402673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Dongye Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No. 107 Yanjiang Road West, Guangzhou, 510120, China. Hauptthemen laut MEDLINE: Atherosclerosis, Nanomedicine, Oxides, Manganese Compounds. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Atherosclerosis (AS) is a common cause of coronary heart disease and stroke. The delivery of exogenous H 2 S and in situ production of O 2 within atherosclerotic plaques can help suppress inflammatory cell infiltration and alleviate disease progression. However, the uncontrolled release of gas donors hinders achieving effective drug concentrations and causes toxic effects. Herein, diallyl trisulfide (DATS)‐loaded metal‐organic cage (MOC)‐68‐doped MnO 2 nanoparticles are developed as a microenvironment‐responsive nanodrug with the capacity for the in situ co‐delivery of H 2 S and O 2 to inflammatory cells within plaques. This nanomedicine exhibited excellent monodispersity and stability and protected DATS from degradation in the circulation. In vitro studies showed that the nanomedicine reduced macrophage polarization toward an inflammatory phenotype and inhibited the formation of foam cells, while suppressing the expression of NOD‐like receptor thermal protein domain associated protein 3 (NLRP3) and interleukin‐1β. In a mouse model of ApoE −/− genotype, the nanomedicine reduces the plaque burden, inflammatory infiltration, and hypoxic conditions within the plaques. Furthermore, the treatment process and therapeutic effects can be monitored by magnetic resonance image (MRI), in real time upon Mn 2+ release from the acidic‐ and H 2 O 2 ‐ microenvironment‐responsive MnO 2 nanoparticles. The DATS‐loaded MOC‐68‐doped MnO 2 ‐based nanodrug holds great promise as a novel theranostic platform for AS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No. 107 Yanjiang Road West, Guangzhou, 510120, China.
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, GBRCE for Functional Molecular Engineering, LIFM, IGCME, School of Chemistry, Sun Yat-Sen University, No. 135 Xingang Road West, Guangzhou, 510275, China.
- Department of Cardiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, No.107 Yanjiang Road West, Guangzhou, 510120, China.
ORCID-Profile: Jun Shen
Förderung
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- GBRCE for Functional Molecular Engineering
Zitieren
APA
Li, D., Chen, J., Lu, Y., Yan, X., Yang, X., Zhang, F., Tang, Y., Cao, M., Wang, J., Pan, M., Su, C., & Shen, J. (2024). Codelivery of Dual Gases with Metal‐Organic Supramolecular Cage‐Based Microenvironment‐Responsive Nanomedicine for Atherosclerosis Therapy. Small. https://doi.org/10.1002/smll.202402673
Vancouver
Li D, Chen J, Lu Y, Yan X, Yang X, Zhang F, et al. Codelivery of Dual Gases with Metal‐Organic Supramolecular Cage‐Based Microenvironment‐Responsive Nanomedicine for Atherosclerosis Therapy. Small. 2024. doi:10.1002/smll.202402673
BibTeX
@article{Li2024,
author = {Li, Dongye and Chen, Jingjing and Lu, Yulin and Yan, Xinyu and Yang, Xieqing and Zhang, Fang and Tang, Yingmei and Cao, Minghui and Wang, Jingfeng and Pan, Mei and Su, Chengyong and Shen, Jun},
title = {Codelivery of Dual Gases with Metal‐Organic Supramolecular Cage‐Based Microenvironment‐Responsive Nanomedicine for Atherosclerosis Therapy},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202402673}
}
EUVIMED